Development and preliminary validation of a risk prediction model for chemotherapy-related nausea and vomiting.
about
The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomitingCohort study of consistency between the compliance with guidelines for chemotherapy-induced nausea and vomiting and patient outcome.Aprepitant and fosaprepitant: a 10-year review of efficacy and safetyAssessment of Symptoms in Cancer Patients Undergoing Chemotherapy in Northern Greece.Palonosetron versus granisetron in combination with aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with gynecologic cancer.Personalized Estimate of Chemotherapy-Induced Nausea and Vomiting: Development and External Validation of a Nomogram in Cancer Patients Receiving Highly/Moderately Emetogenic Chemotherapy.Nausea as a sentinel symptom for cytotoxic chemotherapy effects on the gut-brain axis among women receiving treatment for recurrent ovarian cancer: an exploratory analysis.Late chronotypes are associated with neoadjuvant chemotherapy-induced nausea and vomiting in women with breast cancer.Baseline patient characteristics, incidence of CINV, and physician perception of CINV incidence following moderately and highly emetogenic chemotherapy in Asia Pacific countries.How to improve the prevention of chemotherapy-induced nausea and vomiting? The French NAVI study.Feasibility of using the Multinational Association of Supportive Care in Cancer Antiemesis Tool for assessment of chemotherapy-induced nausea and vomiting at the Tom Baker Cancer Centre.Chemotherapy-induced nausea and vomiting (CINV) and adherence to antiemetic guidelines: results of a survey of oncology nurses.A randomized trial of olanzapine versus palonosetron versus infused ondansetron for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation.Preliminary evaluation of a predictive blood assay to identify patients at high risk of chemotherapy-induced nausea.The burden of chemotherapy-induced nausea and vomiting in children receiving hematopoietic stem cell transplantation conditioning: a prospective study.Guidelines versus individualized care for the management of CINV.
P2860
Q33749052-1EB51779-9098-4711-AE72-042BBE35CEF1Q35232897-2FAB0086-FC3F-48A6-A8A9-DCF4FD055AF8Q35345557-FF265F74-B967-4E4A-BCE1-F2A374EAE890Q36176519-7A0EAA31-9475-42A1-A9C4-653E457808CEQ36205615-994E5AEE-A306-49B0-A91D-3633F08354C3Q36478194-A7857FBE-A152-4372-8E61-B1B116A3CCACQ36840009-1AE74B8E-ABB6-4375-908A-4B5E756B455BQ38864988-BE799D45-BD7E-41FC-8CF0-DCF855C8AB56Q43571282-B4D503DE-37E0-4E3A-B33B-778E38F7D90CQ46106401-F5AF74F9-8429-467C-8067-4623A8D77840Q48073035-E829FDF6-2449-4A3F-88F9-3316A5D711A2Q48127109-E87F4A5D-227A-4194-8976-64AFB62C50EFQ48302132-A1EB0AB9-F393-46D7-BBA6-D4168D79C704Q50227319-78B02B2B-0320-481A-8B65-9567C8DD55D9Q50601534-CB0DF050-E056-4D23-A8CC-930FF10F98B3Q55336299-DDD4553F-41D3-420E-82C3-4E1194FB07D6
P2860
Development and preliminary validation of a risk prediction model for chemotherapy-related nausea and vomiting.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Development and preliminary va ...... y-related nausea and vomiting.
@en
Development and preliminary va ...... y-related nausea and vomiting.
@nl
type
label
Development and preliminary va ...... y-related nausea and vomiting.
@en
Development and preliminary va ...... y-related nausea and vomiting.
@nl
prefLabel
Development and preliminary va ...... y-related nausea and vomiting.
@en
Development and preliminary va ...... y-related nausea and vomiting.
@nl
P2860
P50
P1476
Development and preliminary va ...... y-related nausea and vomiting.
@en
P2093
Z Stamataki
P2860
P2888
P304
P356
10.1007/S00520-013-1843-2
P577
2013-05-30T00:00:00Z